Given a strong drug pipeline and company financials, analysts expect Sanofi stock to do well in 2016. Sanofi ADR (NYSE:SNY) shares closed down 1.68% on December 31, 2015. The stock’s beta value is 1.00. The company has a total market capitalization of $112.90 billion, with 1.31 billion outstanding shares. In terms of sales, the drugmaker …
Category Archives: Featured
Midatech Completes Acquisition of Zuplenz from Galena Biopharma
Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology and other therapeutic areas, announced the successful completion of its previously announced acquisition of Zuplenz (ondansetron), a marketed oncology product from Galena Biopharma, Inc.
RBC Out With Top Specialty Pharmaceutical Stocks to Buy for 2016
If there was a sector that joined energy in taking a beating in 2015, it was specialty pharmaceuticals.
Food, Drug & Device Law Alert – FDA Issues Draft Guidance on Voluntary Labeling of GMO Foods
The Food and Drug Administration (FDA) recently issued a draft guidance for manufacturers of human and animal food who want the labels of their products to indicate whether (or not) the products include ingredients derived from genetically engineered plants. The FDA states that its primary interest in the topic is to ensure such labels are …